What does this research mean for the field?

Inflammatory bowel disease (IBD) increases the risk of end-stage renal disease (ESRD) by nearly 50%, with Crohn's disease (CD) showing a greater risk than ulcerative colitis (UC). Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The study assesses the incidence of end-stage renal disease in inflammatory bowel disease patients and identifies risk factors.

February 16, 2026Open Access

Poster Session II - A233 INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH AN INCREASED RISK OF END-STAGE RENAL DISEASE: A POPULATION-BASED COHORT STUDY

Key Points

The study assesses the incidence of end-stage renal disease in inflammatory bowel disease patients and identifies risk factors.
Retrospective population-based cohort study
Utilized the University of Manitoba IBD Epidemiology Database
Matched 12,639 IBD patients with 126,180 controls
Risk factors assessed using proportional hazard regression and nested case-control logistic regression
IBD patients had higher incidence of dialysis (1.48% vs 0.82%) and kidney transplantation (0.25% vs 0.10%) than controls
IBD was an independent predictor of ESRD with a hazard ratio of 1.53
Crohn's disease showed a higher risk for ESRD (HR = 1.93) compared to ulcerative colitis (HR = 1.28)
Traditional risk factors like diabetes and hypertension were strong predictors
Oral steroid treatment, allopurinol use, and bowel surgery significantly predicted dialysis initiation

Abstract

Abstract Background Inflammatory bowel disease (IBD) patients frequently develop extraintestinal manifestations, including renal complications. However, the incidence and risk factors for end-stage renal disease (ESRD) in IBD remain poorly characterized. Aims This study aims to assess the incidence of ESRD in IBD, compare its risk with the general population, and identify predictors of ESRD. Methods This was a retrospective population-based cohort study using the University of Manitoba IBD Epidemiology Database linked to administrative healthcare data from 1984-2023 (12,639 IBD patients matched with 126,180 controls). ESRD was defined as requiring any two claims for outpatient dialysis within a 1-year period. Predictive factors were identified using proportional hazard regression and nested case-control logistic regression analyses. A233 Table 1: Baseline characteristic of all participants in cohort Results IBD patients had significantly higher incidence of dialysis (1.48% vs 0.82%, p 0.0001) and kidney transplantation (0.25% vs 0.10%, p 0.0001) than controls. IBD was an independent predictor of ESRD (HR = 1.53, 95% CI 1.23-1.90), with stronger associations in CD (HR = 1.93, 95% CI 1.39-2.68) than UC (HR = 1.28, 95% CI 0.96-1.72). Traditional risk factors including diabetes (HR = 3.82, 95% CI 3.22-4.53), hypertension (HR = 1.91, 95% CI 1.58-2.30), and congestive heart failure (HR = 6.37, 95% CI 5.25-7.72) remained strongly predictive. Within the IBD population, oral steroid treatment (OR = 2.0, 95%CI 1.06-3.81), allopurinol use (OR = 4.06, 95% CI 1.49-11.1), and bowel surgery (OR = 2.77, 95% CI 1.51-5.09) significantly predicted dialysis initiation Conclusions IBD increases ESRD risk by nearly 50%, with CD showing greater risk than UC. Bowel surgery, allopurinol use, and oral steroid therapy are important predictors, emphasizing the necessity of careful renal monitoring in IBD patients. Kaplan–Meier survival curves showing the cumulative incidence of all-cause mortality during follow-up among patients with Crohn’s disease (CD), ulcerative colitis (UC), and controls after initiation of dialysis. None

Read Full Paperexternally

Mark Helpful

Bookmark

Relay

View Full Paper